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BACKGROUND: We aimed to develop and validate a measurement tool to assess cancer awareness in the general population: the
cancer awareness measure (CAM).
METHODS: Items assessing awareness of cancer warning signs, risk factors, incidence, screening programmes and attitudes towards help
seeking were extracted from the literature or generated by expert groups. To determine reliability, the CAM was administered to a
university participant panel (n¼148), with a sub-sample (n¼94) completing it again 2 weeks later. To establish construct validity,
CAM scores of cancer experts (n¼12) were compared with those of non-medical academics (n¼21). Finally, university students
(n¼49) were randomly assigned to read either a cancer information leaflet or a leaflet with control information before completing
the measure, to ensure the CAM was sensitive to change.
RESULTS: Cognitive interviewing indicated that the CAM was being interpreted as intended. Internal reliability (Cronbach’s a¼0.77)
and test–retest reliability (r¼0.81) were high. Scores for cancer experts were significantly higher than those for non-medical
academics (t(31)¼6.8, Po0.001). CAM scores were higher among students who received an intervention leaflet than the control
leaflet (t(47)¼4.8, Po0.001).
CONCLUSIONS: These studies show the psychometric properties of the CAM and support its validity as a measure of cancer awareness
in the general population.
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Cancer is a major burden worldwide (Parkin et al, 2005) and
a leading cause of mortality in the United Kingdom, claiming
over 150000 lives a year (Cancer Research UK, 2009). Around
289000 new cases are diagnosed annually in the United Kingdom,
with one in three people developing cancer in their lifetime
(Cancer Research UK, 2008a). Despite progress in reducing
mortality rates, changes in the age distribution of the population
will mean that cancer incidence will continue to rise (Boyle
and Ferlay, 2005). In recent years, the UK Governments have
developed strategies aimed at reducing cancer incidence and
mortality; the most recent for England is the NHS Cancer Reform
Strategy (Department of Health, 2007), which emphasises the
importance of raising public awareness of early warning signs and
risk factors.
Existing evidence indicates that public awareness of warning
signs is poor. In a population-based survey in England, fewer than
1 in 10 respondents could recall Europe Against Cancer’s seven
warning signs for cancer (Brunswick et al, 2001). These findings
are not unique to this study nor limited to generic warning signs;
awareness is also low for a range of cancers (Wardle et al, 2001;
Grunfeld et al, 2002; McCaffery et al, 2003; Rudberg et al, 2005;
West et al, 2006; FitzGerald et al, 2008).
European comparisons show the United Kingdom to have lower
than average cancer survival rates (Coleman et al, 2003), part of
which is due to patients in the United Kingdom having more
advanced stage of disease at diagnosis. Later presentation of cancer
symptoms in the United Kingdom than in other European
countries may contribute to this. Raising public awareness of
warning signs and promoting prompt presentation could reduce
patient-attributable delay and result in diagnosis at an earlier stage
(Ramirez et al, 1999; Richards et al, 1999; Macdonald et al, 2006).
Awareness of cancer risk factors except for tobacco use is also
low (Wardle et al, 2001; Grunfeld et al, 2002; McCaffery et al, 2003;
Marlow et al, 2007; Redeker et al, 2009), particularly in relation
to weight, alcohol consumption, high-fat diet, exercise and older
age. It is estimated that around half of all cancers could be
prevented by modification of lifestyle risk factors (Cancer
Research UK, 2008b). Although awareness alone may not be
sufficient to motivate change, it is unrealistic to expect changes in
behaviour if people are not at least aware of the risk factors
(Viswanath et al, 2006).
There is currently no validated measure of general public
awareness of cancer, although several questionnaires have been *Correspondence: Professor J Wardle; E-mail: j.wardle@ucl.ac.uk
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Rees et al, 2003; Green and Kelly, 2004). In a review of the
literature, Adlard and Hume (2003) also identified lack of
agreement over the best way to measure cancer awareness. As a
result, different question formats are often used. Questions asked
in a prompted (recognition) format can elicit higher apparent
levels of cancer awareness than those asked in an unprompted
(recall) format (Waller et al, 2004). Such variations in responses
make it difficult to establish current levels of awareness or make
comparisons across studies.
Education campaigns designed to improve awareness of cancer
in the general population have been carried out, but without
validated instruments, it is difficult to evaluate effectiveness. This
highlights the need for a measure that will enable both researchers
and campaigning groups to evaluate the impact of their activities.
The aim of this research was therefore to develop and validate a
standardised measurement tool to assess cancer awareness. A good
measure should have face validity, the questions should be
interpreted as intended by the target audience, and it should give
stable results across two occasions between which knowledge has
not changed (test–retest reliability). Good reliability is essential
for obtaining precise estimates of knowledge and for giving the
best statistical power to detect change. A good measure also needs
to be valid, that is, groups who by general consensus have a higher
standing on the relevant constructs should score higher; in this
case, we compared cancer experts and equivalently educated non-
experts to test the instrument’s sensitivity to knowledge. Finally, if
it is to have value in assessing the impact of public health
interventions, it should be sensitive to change; we tested this by
comparing scores before and after exposure to a brief educational
intervention.
MATERIALS AND METHODS
Generation of items
Following a review of the literature, existing awareness ques-
tionnaires were examined and relevant items extracted. This was
supplemented with a review of the ‘grey’ literature (i.e. unpub-
lished surveys carried out by cancer charities and other organisa-
tions) to include items not published in academic journals.
Following this review, an item pool consisting of 137 items was
created. These covered a range of topics including awareness of
warning signs and risk factors, cancer incidence and awareness of
national screening programmes. Items were then excluded if they
were poorly worded, used terminology not frequently used in the
United Kingdom (e.g. Pap test) or were attitudinal in nature (e.g. ‘I
believe there are no early symptoms of cancer’). Items relating to
awareness of the purpose of screening, the benefits of early
detection and cancer survival rates were also omitted from the
measure because the primary focus was symptom recognition. In
addition, the research team generated several items specifically for
the instrument that had not been used in previous questionnaires.
Once consensus over the items had been reached, a first version
of the cancer awareness measure (CAM) was circulated to a panel
of experts (n¼16) including academic researchers, cancer charity
representatives, general practitioners, oncologists and experts in
the field of questionnaire design, to ensure content validity and
face validity. In addition, cognitive interviews were conducted with
the general public. These encourage respondents to verbalise their
cognitions, making it possible to identify areas where interpreta-
tion of the questions is ambiguous (Collins, 2003). Cognitive
interviews were conducted with a small sample of participants
(n¼6) aged between 23 and 70 years. Minor modifications were
made to the phrasing of several items as a result.
The final version of the CAM consisted of the following: (i) 10
items on awareness of warning signs (one open-ended question
and nine recognition items); (ii) nine items on anticipated time to
seek medical advice (asking about each of the warning signs); (iii)
10 items on barriers to seeking medical advice (covering a range of
practical, service delivery and emotional barriers); (iv) 13 items on
awareness of risk factors (one open-ended question, 11 recognition
items and one asking participants to rank the importance of
different types of risk factor); (v) seven items on cancer incidence
(one asking about overall cancer incidence and six asking about
the three most common cancers for men and women) and (vi) six
items on awareness of NHS screening programmes (asking about
awareness of the cervical, breast and bowel screening programmes
and the age from which screening is offered for each).
Validating the CAM
Validating the CAM was a three-stage process, with each stage
assessing a different aspect of reliability or validity. The aims of
stage one were to establish internal reliability and test–retest
reliability and carry out item analyses; stage two was designed to
establish construct validity and stage three to ensure that the
measure was sensitive to increases in levels of awareness.
Data were analysed using SPSS 14.0. Parametric statistics (e.g.
Pearson’s correlation, t-tests) were performed to analyse the
reliability and validity of the measure. Descriptive statistics were
used to examine the characteristics of the samples.
RESULTS
Stage 1: Internal reliability and test–retest reliability
Sample and methods Five hundred and fifty-one e-mails were
sent to a research ‘participant panel’ with an invitation to complete
the CAM anonymously online. The panel consisted of members of
the general public who had previously indicated that they were
willing to participate in research. The questionnaire was completed
in the available time by 148 (27%) panel members. The majority of
respondents were women (76%), white (86%) and educated to
degree level (68%) (Table 1). Two weeks later, respondents were
asked to complete the CAM a second time. Two weeks was judged
as an adequate period of time for respondents neither to recall
precisely their original answers, nor to be likely to have had any
major changes in cancer awareness. Ninety-four participants
(63%) completed the questionnaire again. Data were matched
using e-mail addresses.
Internal reliability assesses the extent to which all the
questionnaire items measure the same underlying construct (Kline,
2000). It is assessed using Cronbach’s a and a minimum score of
0.7 should be obtained for a questionnaire to be considered
reliable (Bland and Altman, 1997). To assess the stability of a
questionnaire over time, a measure of test–retest reliability must
be calculated (Kline, 2000). Pearson’s correlations are computed
using scores from two time points. It is important to identify
whether respondents find items too easy or too difficult to answer,
and it is recommended that items are excluded if they are
answered correctly by 480% or o20% of participants (Kline,
2000). Item discrimination reveals the ability of an individual item
to discriminate between those who have high or low overall
knowledge scores, and items should be discarded if an item-to-
total correlation of o0.2 is yielded (Streiner and Norman, 1995).
Analysis and results
Internal reliability A Cronbach’s a of 0.77 was achieved for the
whole questionnaire, with the following a values obtained for each
sub-section: warning signs (9 recognition items) 0.77; anticipated
time to seek medical advice (9 items) 0.90; barriers to seeking
medical advice (10 items) 0.73; risk factors (11 recognition items)
0.79; NHS screening programmes (6 items) 0.54. Despite obtaining
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awareness of NHS screening programmes on the grounds of
content validity.
Test–retest reliability With the exception of incidence of
common cancers, high correlations over time were found for all
sections (Table 2), all of which reached statistical significance
(Po0.001).
Item difficulty The majority of items matched the criterion of
being answered correctly by o80% and 420% of participants. The
few that did not were retained on the basis of face validity (e.g.
smoking being a risk factor for cancer, a lump being a warning
sign for cancer), because respondents might be surprised if they
were not included.
Item discrimination Analyses revealed item-to-total correlations
40.2 for each item, suggesting all items in the CAM should be
retained.
Stage 2: Construct validity: cancer ‘experts’ vs non-medical
academics
Sample and methods The ‘known-groups’ method was used to
establish construct validity. If the scores of two groups known to
differ in levels of cancer awareness are significantly different then
the validity of the questionnaire is supported (DeVellis, 2003).
Cancer experts (n¼12) were recruited from a large cancer charity,
while the ‘non-expert’ group comprised non-medical academics
(n¼21) recruited from a range of departments in the university.
Participants were invited to take part by e-mail and could either
complete the questionnaire electronically or print it out and
complete a paper copy. The demographic characteristics of the
samples can be seen in Table 3.
Analyses and results
The cancer experts scored consistently higher than the non-
medical academics (Table 4) and, with the exception of incidence,
this reached statistical significance for each awareness section.
Although differences in incidence scores were not statistically
significant, the standard deviations varied considerably (0.8 for the
cancer experts and 12.5 for the non-medical group), suggesting
that experts were more consistent at answering the questions.
Stage 3: Sensitivity to change: brief educational
intervention
Sample and methods A convenience sample of 49 undergraduate
and postgraduate students was recruited to participate in this
stage. They were randomised to receive one of two leaflets to read
before completing a paper copy of the CAM. One was an
educational leaflet (‘Cancer: the facts’), which included informa-
tion on the aetiology of cancer, incidence rates, warning signs, risk
factors and available NHS screening programmes. The other was a
control leaflet (‘Recycle to save the environment’).
Table 1 Demographic characteristics of the online study sample
(n¼148)
N %
a
Gender
Male 36 24.3
Female 112 75.7
Age (years)
18–24 40 27.0
25–34 33 22.3
35–44 9 6.1
45–54 11 7.4
55–64 39 26.4
65 and over 16 10.8
Ethnic origin
White 126 85.1
Other 20 13.5
Employment status
Employed full-time 37 25.0
Employed part-time 11 7.4
Student 62 41.9
Other 38 25.7
Highest qualification obtained
No qualifications 2 1.4
O level/GCSE 5 3.4
A level 14 9.5
Degree or above 101 68.2
Still studying 23 15.5
Marital status
Single 58 39.2
Married/cohabiting 75 50.7
Divorced/widowed 14 9.5
aSome variables do not add up to 100% due to missing data.
Table 2 Test–retest reliability of the CAM (n¼94)
Awareness section Test–retest reliability
Warning signs 0.73
Anticipated time to seek advice 0.86
Barriers to seeking advice 0.72
Risk factors 0.73
Incidence per 100 people 0.78
Incidence – common cancers 0.33
Screening programmes 0.75
Screening programmes – age at first invitation 0.77
Total 0.81
Abbreviation: CAM¼cancer awareness measure.
Table 3 Demographic characteristics of the two samples (n¼33)
Non-medical academics
(n¼21)
Cancer experts
(n¼12)
n % n %
Age (years)
25–34 2 9.5 7 58.3
35–44 8 38.1 4 33.3
45–54 9 42.9 — —
55–64 2 9.5 1 8.3
Gender
Male 9 42.9 1 8.3
Female 12 57.1 11 91.7
Highest qualification
Degree — — 2 16.7
Masters 2 9.5 3 25.0
PhD or equivalent 19 90.5 5 41.7
Other — — 2 16.7
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(Table 5), with no significant differences in age, gender or ethnic
origin being observed.
Analyses and results
The cancer education group scored consistently higher than the
control group and, excluding results for cancer incidence, this
reached statistical significance for all awareness sections (Table 6).
Not surprisingly for such a brief intervention there was
comparatively small mean difference between the education and
control groups, but there was also differentiated variability with
standard deviations of 3.4 (education) and 11.5 (control).
DISCUSSION
There has been a good deal of interest in public awareness of
cancer, but in most studies measures are developed on an ad hoc
basis, often with a specific population in mind, and rarely
address psychometric properties. This not only limits general-
isation to other groups, but also precludes comparisons between
studies or groups.
The CAM was developed to provide a validated measure of
awareness of early warning signs and risk factors, and barriers to
seeking medical advice. Reliability of the measure was high, with a
total Cronbach’s a of 0.77 and all but one of the sub-scales
reaching the recommended cutoff of 0.7. Test–retest reliability was
also good, with all sub-scales except awareness of the incidence of
common cancers being 40.7. The low reliability of the incidence
items probably reflects the fact that people had little idea and were
just guessing the answers; and not making the same guess on
different occasions. This is understandable because although
people may be able to identify the most common cancer in men
(prostate) and women (breast), the second and third most
common cancers are rarely publicised as such. However, given
that awareness of the most common cancers could improve, these
items were retained.
Construct validity was established using a ‘known-groups’
design. Overall, those with expertise in cancer achieved signifi-
cantly higher mean scores than non-medical academics, showing
the CAM has the ability to distinguish between groups with
established differences in levels of awareness. In addition, the CAM
was shown to be sensitive to increases in awareness following a
brief educational intervention.
Limitations
The limitations to the validation of the measure should be noted.
The mode of administration varied across different stages of
piloting, including online and with paper-and-pencil versions.
Concerns have been raised about the quality of survey data
collected through different modes (Bowling, 2005), although the
mode of administration was consistent within each stage of
piloting so the potential impact would have been kept to a
minimum. For use in population surveys, we suggest that the CAM
should ideally be given in an interview format to prevent
participants from changing their previous answers in response to
the prompted format of subsequent questions. The pilot samples
tended to be female and educated to degree level, which limits
generalisation to other populations. However, given that the CAM
was sensitive to differences in levels of awareness in a highly
educated academic sample, it is likely that differences would be
equally marked in less educated populations. To date, the CAM is
only available in English, but we anticipate that it will be translated
into a range of languages and available for use in the future.
Future work
This paper describes the development of the generic CAM. Work is
now underway to develop tumour-specific versions of the CAM,
including breast, prostate, bowel, cervical and ovarian, and more
tumour-specific versions are planned. It is anticipated that the
CAM will evolve over time to reflect advances in knowledge, and to
Table 4 Differences in awareness scores between non-medical
academics and cancer experts (n¼33)
Awareness section
Non-medical
academics
(n¼21)
Cancer
experts
(n¼12)
(max score) Mean s.d. Mean s.d. t (31)
Warning signs (9) 7.3 2.4 8.8 0.4 2.9*
Risk factors (55) 42.3 4.1 50.8 4.7 5.4**
Incidence per 100 people
a 34.0 12.5 33.3 0.8  0.2
Incidence – common cancers (6) 2.3 1.2 3.5 1.4 2.7*
Screening programmes (3) 1.9 0.4 3.0 0.0 9.4**
Screening programmes – age at
first invitation (3)
0.7 0.6 2.2 1.1 4.2**
Total (77) 57.2 5.9 69.3 5.6 6.8**
*Po0.05. **Po0.001.
aParticipants were given a score of ‘1’ if their answer was
correct (correct range, 30–36).
Table 5 Demographic characteristics of the two samples (n¼49)
Control (n¼24) Intervention (n¼25)
n % n %
Age (years)
18–24 9 62.5 12 48.0
25–34 15 37.5 12 48.0
35+ — — 1 4.0
Gender
Male 9 37.5 9 36.0
Female 15 62.5 16 64.0
Ethnic origin
White 17 70.8 16 64.0
Other 7 29.2 9 36.0
Table 6 Differences in awareness scores between control and
intervention participants (n¼49)
Awareness section
Control
(n¼24)
Intervention
(n¼25)
(max score) Mean s.d. Mean s.d. t (47)
Warning signs (9) 6.0 1.9 7.3 0.9 2.7*
Risk factors (55) 39.8 4.6 43.7 5.0 2.8*
Incidence per 100 people
a 29.2 11.5 32.8 3.4 1.5
Screening programmes (3) 1.8 0.7 2.7 0.7 4.2**
Screening programmes – age at
first invitation (3)
0.6 0.6 1.8 0.9 5.2**
Total (71)
b 48.7 5.8 56.3 5.7 4.6**
*Po0.05. **Po0.001.
aParticipants were given a score of ‘1’ if their answer was
correct (correct range, 30–36).
bThis total score does not include all components of
the awareness measure. The intervention leaflet did not contain information on
timely presentation, barriers to seeking medical advice or incidence of most common
cancers, so these items have been omitted from the analysis.
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CONCLUSION
The CAM is a reliable and valid measure of cancer awareness and
can be used to provide a comprehensive assessment of cancer
awareness. The CAM has now been administered in a large-scale,
population-based, British sample with a substantial ethnic boost
sample, using a face-to-face, home-based interview methodology,
so standardised population data for the United Kingdom are
available for reference (Robb et al; Waller et al). In addition, the
CAM can be used by researchers to develop informed interven-
tions and to assess the impact of interventions designed to target
gaps in public awareness of cancer either in whole populations or
specific sub-groups.
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